author-photo

Rita Axelrod

Thomas Jefferson University

85

Papers

6214

Citations

Citation Trend

Filter By

Papers (63) Sort By

Journal Conference Others

861MO Spatial distribution of CD8+ and FoxP3+ in a window of opportunity for durvalumab (MEDI4736) plus metformin trial in squamous cell carcinoma of the head and neck (HNSCC)

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Pathologic and radiographic responses in a window of opportunity for durvalumab plus metformin trial for squamous cell carcinoma of the head and neck (HNSCC).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
869P Nivolumab (Nivo) and ipilimumab (Ipi) combined with radiotherapy (RT) in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN): Updated results of a pilot study

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Neoadjuvant nivolumab (N) plus cisplatin (C)/pemetrexed (P) or cisplatin /gemcitabine (G) in resectable NSCLC.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (12)
Discordant Responses Between Primary Head and Neck Tumors and Nodal Metastases Treated With Neoadjuvant Nivolumab: Correlation of Radiographic and Pathologic Treatment Effect

2020 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (6)
923P Immune alterations in a window of opportunity for durvalumab (MEDI4736) plus metformin trial in squamous cell carcinoma of the head and neck (SCCHN)

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
968P Neoadjuvant nivolumab (N) plus weekly carboplatin (C) and paclitaxel (P) outcomes in HPV(-) resectable locally advanced head and neck cancer

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Neoadjuvant nivolumab (N) plus weekly carboplatin (C) and paclitaxel (P) in resectable locally advanced head and neck cancer.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
1129PWindow of opportunity for durvalumab (MEDI4736) plus metformin trial in squamous cell carcinoma of the head and neck (SCCHN): Interim safety analysis

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Racial Disparities in Head and Neck Cancers in an Urban Hospital

2019
Show All
- Source
- Cite
- Save
Citations (0)